IMP-761
- Generic Name
- IMP-761
A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Immutep S.A.S.
- Target Recruit Count
- 49
- Registration Number
- NCT06637865
- Locations
- 🇳🇱
CHDR, Leiden, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath